[go: up one dir, main page]

SK150196A3 - Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use - Google Patents

Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use Download PDF

Info

Publication number
SK150196A3
SK150196A3 SK1501-96A SK150196A SK150196A3 SK 150196 A3 SK150196 A3 SK 150196A3 SK 150196 A SK150196 A SK 150196A SK 150196 A3 SK150196 A3 SK 150196A3
Authority
SK
Slovakia
Prior art keywords
cys
peptide
gly
pro
side chains
Prior art date
Application number
SK1501-96A
Other languages
English (en)
Slovak (sk)
Inventor
Hakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK150196A3 publication Critical patent/SK150196A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SK1501-96A 1995-03-24 1996-03-22 Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use SK150196A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501067A SE9501067D0 (sv) 1995-03-24 1995-03-24 New peptides
PCT/SE1996/000365 WO1996030397A1 (en) 1995-03-24 1996-03-22 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
SK150196A3 true SK150196A3 (en) 1997-06-04

Family

ID=20397676

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1501-96A SK150196A3 (en) 1995-03-24 1996-03-22 Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use

Country Status (20)

Country Link
US (1) US6228373B1 (xx)
EP (1) EP0785945A1 (xx)
JP (1) JPH10501003A (xx)
AR (1) AR002724A1 (xx)
AU (1) AU5166296A (xx)
BR (1) BR9605890A (xx)
CA (1) CA2189656A1 (xx)
CZ (1) CZ344096A3 (xx)
EE (1) EE9600208A (xx)
HU (1) HUP9603537A3 (xx)
IL (1) IL117615A0 (xx)
IS (1) IS4382A (xx)
NO (1) NO964959D0 (xx)
NZ (1) NZ304468A (xx)
PL (1) PL317348A1 (xx)
SE (1) SE9501067D0 (xx)
SK (1) SK150196A3 (xx)
TR (1) TR199600932T1 (xx)
WO (1) WO1996030397A1 (xx)
ZA (1) ZA962345B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250707A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methionine-containing peptides with immunomodulatory effects
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
DE59907233D1 (de) * 1998-12-21 2003-11-06 Ivf Hartmann Ag Neuhausen Am R Infektionsschutz-tampon
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
FR2872042B1 (fr) * 2004-06-29 2006-09-15 Soc Extraction Principes Actif Utilisation d'un dipeptide dimerise en tant qu'agent actif dans ou pour la preparation une composition cosmetique et/ou dermatologique
GB2442408B (en) 2005-04-25 2010-06-30 Cadila Pharmaceuticals Ltd Mycobacterium W as an adjuvant
GB0524884D0 (en) 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
KR20140001257A (ko) 2008-05-13 2014-01-06 유니버시티 오브 캔사스 금속 추출 펩타이드(ｍａｐ) 태그 및 관련된 방법
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.
FR2622700B1 (fr) * 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
AU655599B2 (en) 1990-09-11 1995-01-05 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)
WO1993000108A1 (en) 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
KR100260342B1 (ko) 1991-10-16 2000-07-01 스타세이 엘. 첸링 더마토파고이드로 부터 유래된 알레르겐의 t세포 에피토프
BR9406652A (pt) 1993-03-05 1996-09-10 Cytel Corp Composição
IL106214A (en) 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
WO1996001318A1 (en) 1994-07-05 1996-01-18 Steeno Research Group A/S Immunomodulators
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
EE9600208A (et) 1997-06-16
AU5166296A (en) 1996-10-16
IS4382A (is) 1996-11-08
PL317348A1 (en) 1997-04-01
NO964959L (no) 1996-11-21
EP0785945A1 (en) 1997-07-30
JPH10501003A (ja) 1998-01-27
HU9603537D0 (en) 1997-02-28
NO964959D0 (no) 1996-11-21
US6228373B1 (en) 2001-05-08
HUP9603537A2 (en) 1997-08-28
IL117615A0 (en) 1996-07-23
SE9501067D0 (sv) 1995-03-24
HUP9603537A3 (en) 1998-03-02
NZ304468A (en) 1999-02-25
AR002724A1 (es) 1998-04-29
BR9605890A (pt) 1997-09-23
ZA962345B (en) 1996-09-25
CZ344096A3 (en) 1997-05-14
CA2189656A1 (en) 1996-10-03
TR199600932T1 (tr) 1997-03-21
WO1996030397A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
CZ308395A3 (en) Complex for b12 vitamin reception, process of its preparation, compositions containing thereof and its use
SK15096A3 (en) Therapeutic peptide derivatives and a method of their application
RU2114118C1 (ru) Пептиды, или их фармацевтически приемлемые кислоты, или соли, фармацевтическая композиция, обладающая антагонистической активностью по отношению к бомбезину, способ лечения рака у млекопитающих
AU2010244857A1 (en) High penetration prodrug compositions of peptides and peptide-related compounds
JP2016065018A (ja) Ｃｘｃｒ７結合剤およびｃｘｃｒ７結合剤を含有する医薬組成物
SK150196A3 (en) Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
US20170173107A1 (en) Compstatin Analogs With Improved Potency and Pharmacokinetic Properties
US9821072B2 (en) Activated neurotensin molecules and the uses thereof
WO1998012217A1 (en) Heterodimer peptides with immunomodulatory effect
JP2001514659A (ja) ドラスタチン−１５誘導体とタキサンとの併用
US6316414B1 (en) Somatostatin analogs for the treatment of cancer
HUT62604A (en) Process for producing peptides for treating tissue proliferation and pharmaceutical compositions comprising same
CA2405704C (en) Bombesin analogs for treatment of cancer
WO1998012219A1 (en) Methionine, penicillamine and cysteine-analogue containing peptides having immunomodulating activity
JP2004002331A (ja) 肝臓癌の治療
CA2405724C (en) Substance p analogs for the treatment of cancer
EP1198478B1 (en) Somatostatin analogs and their use for the treatment of cancer
US6596692B1 (en) Substance P analogs for the treatment of cancer
JP2010150253A (ja) 肝癌を治療するための薬剤
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
US6989371B1 (en) Bombesin analogs for treatment of cancer
WO1998012218A1 (en) Tri- or polysulphide containing peptides having immunomodulating activity
WO1998012213A2 (en) Cysteine containing peptides
JPS63303999A (ja) バソプレシン拮抗剤